Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Annalisa De Vellis"'
Autor:
Sergio Storti, Michele Spina, Emanuela Anna Pesce, Flavia Salvi, Michele Merli, Alessia Ruffini, Giuseppina Cabras, Annalisa Chiappella, Emanuele Angelucci, Alberto Fabbri, Anna Marina Liberati, Monica Tani, Gerardo Musuraca, Annalia Molinari, Maria Pia Petrilli, Carmela Palladino, Rosanna Ciancia, Andrea Ferrario, Cristiana Gasbarrino, Federico Monaco, Vincenzo Fraticelli, Annalisa De Vellis, Francesco Merli, Stefano Luminari
Publikováno v:
Haematologica, Vol 103, Iss 8 (2018)
We conducted a phase II study to assess activity and safety profile of bendamustine and rituximab in elderly patients with untreated diffuse large B-cell lymphoma (DLBCL) who were prospectively defined as frail using a simplified version of the Compr
Externí odkaz:
https://doaj.org/article/113d9dc70ef24344a9ccaa66f023382d
Autor:
Fiorina Giona, Stefania Mariani, Lucio Gnessi, Maria Luisa Moleti, Massimiliano Rea, Annalisa De Vellis, Deborah Marzella, Anna Maria Testi, Robin Foà
Publikováno v:
Haematologica, Vol 98, Iss 3 (2013)
Externí odkaz:
https://doaj.org/article/08f46ef439f04cb584b6d452501eb6e6
Autor:
Sergio, Storti, Michele, Spina, Emanuela Anna, Pesce, Flavia, Salvi, Michele, Merli, Alessia, Ruffini, Giuseppina, Cabras, Annalisa, Chiappella, Emanuele, Angelucci, Alberto, Fabbri, Anna Marina, Liberati, Monica, Tani, Gerardo, Musuraca, Annalia, Molinari, Maria Pia, Petrilli, Carmela, Palladino, Rosanna, Ciancia, Andrea, Ferrario, Cristiana, Gasbarrino, Federico, Monaco, Vincenzo, Fraticelli, Annalisa, De Vellis, Francesco, Merli, Stefano, Luminari
Publikováno v:
Haematologica
We conducted a phase II study to assess activity and safety profile of bendamustine and rituximab in elderly patients with untreated diffuse large B-cell lymphoma (DLBCL) who were prospectively defined as frail using a simplified version of the Compr
Autor:
Robin Foà, Massimiliano Rea, Vincenzo Federico, Alessandra Micozzi, Giuseppe Gentile, Gregorio Antonio Brunetti, Giuliana Alimena, Michela Sali, Giovanni Delogu, Corrado Girmenia, Roberto Latagliata, Massimo Breccia, Salvatore Giacomo Morano, Veronica Valle, Caterina Mercanti, Annalisa De Vellis
Publikováno v:
Acta Haematologica. 126:1-7
Data derived from epidemiologic surveillance adopted at our center in hematologic and stem cell transplant patients during the 2009 influenza A (H1N1)v pandemic are reported. Of the 52 patients with influenza-like disease we observed, 37 underwent a
Autor:
Anna Maria Testi, Alfonso Piciocchi, Salma Abbas Al-Hadad, Robin Foà, Raghad Majid Al-Saeed, Amir Fadhil Al-Darraji, Mazin Faisal Al-Jadiry, Stefania Uccini, Maria Luisa Moleti, Annalisa De Vellis
Publikováno v:
Pediatric Blood & Cancer. 56:560-567
Background An adapted LMB 96 derived protocol for B-cell non-Hodgkin lymphoma (NHL) was implemented at the pediatric oncology unit of the Children Welfare Teaching Hospital in Baghdad (Iraq) from 2000 to present. The purpose was to evaluate the feasi
Autor:
Maria Luisa Moleti, Robin Foà, Anna Maria Testi, Fiorina Giona, Massimiliano Rea, Lucio Gnessi, Stefania Mariani, Deborah Marzella, Annalisa De Vellis
Imatinib mesylate (IM, Glivec®) and the 2 nd generation tyrosine kinase inhibitors (TKIs) (dasatinib and nilotinib) are the standard treatment for children and adults with chronic myeloid leukemia (CML). IM inhibits all ABL tyrosine kinases and sele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6abd92997914dc08d658292376511e17
http://hdl.handle.net/11573/483491
http://hdl.handle.net/11573/483491
Autor:
Serelina Coluzzi, Valerio Cecinati, Anna Maria Testi, Annalisa De Vellis, Mariella D'Angiò, Fulvia Brugnoletti, Maria Chiara De Nicolò
Publikováno v:
Journal of pediatric hematology/oncology. 34(4)
We discuss an unusual clinical presentation of childhood Hodgkin lymphoma; a 16-year-old girl was referred for Coombs-positive severe anemia, thrombocytopenia, and asymptomatic anterior mediastinal mass. Bone marrow examination showed no evidence of
Autor:
Maria Luisa Moleti, Salma Abbas Al Hadad, Mazin Faisal Al Jadiry, Amir Fadhil Al Darraji, Raghad Majid Al Saeed, Annalisa De Vellis, Alfonso, Piciocchi, Uccini, Stefania, Foa, Roberto, Testi, Anna Maria
Publikováno v:
Pediatric bloodcancer. 56(4)
An adapted LMB 96 derived protocol for B-cell non-Hodgkin lymphoma (NHL) was implemented at the pediatric oncology unit of the Children Welfare Teaching Hospital in Baghdad (Iraq) from 2000 to present. The purpose was to evaluate the feasibility and
Autor:
Fiorina Giona, Anna Maria Testi, Robert Foa, Stefania Varotto, Maria Caterina Putti, Anna Leszl, Maria Luisa Moleti, Daniela Diverio, Mauro Nanni, Giuseppe Saglio, Enrico Marco Gottardi, Vittorio Nunes, Annalisa De Vellis
Imatinib mesylate (IM), a BCR-ABL tyrosine kinase inhibitor, is an effective therapy for CML in adults and has shown efficacy in children with Ph+ leukemias. The aim of this study was to evaluate the efficacy of IM in Ph+ CML patients (pts) in CP age
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9939cbd019189164b74ba852846b9d90
http://hdl.handle.net/11573/413870
http://hdl.handle.net/11573/413870
Autor:
Anna Maria Testi, Fiorina Giona, Stefania Mariani, Robert Foa, Mariella D'Angiò, Maria Luisa Moleti, Lucio Gnessi, Bruna De Masi, Annalisa De Vellis
Imatinib, a BCR-ABL tyrosine kinase inhibitor, is an effective treatment for adults and children with CML. However, the in vivo inhibition of the PDGF receptor and c-kit in normal cells may have clinical side effects: altered bone and mineral metabol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8b3fa0ecd5aaebece08435787b530a6
http://hdl.handle.net/11573/413876
http://hdl.handle.net/11573/413876